Evidence map›Paper›PMID 39300964›Full record

ArticleCancer medicine2024

Utilizing patient data: A tutorial on predicting second cancer with machine learning models.

Hossein Sadeghi, Fatemeh Seif, Erfan Hatamabadi Farahani, Soraya Khanmohammadi, Shahla Nahidinezhad

Abstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Analyzing Secondary Cancer Risk: A Machine Learning Approach.Asian Pacific journal of cancer prevention : APJCP · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hossein SadeghiDepartment of Physics, Faculty of Sciences, Arak University, Arak, Iran.ORCID https://orcid.org/0000-0002-8772-951X
Fatemeh SeifDepartment of Radiotherapy and Medical Physics, Arak University of Medical Sciences & Khansari Hospital, Arak, Iran.
Erfan Hatamabadi FarahaniDepartment of Physics, Faculty of Sciences, Arak University, Arak, Iran.
Soraya KhanmohammadiIndustrial and Systems Engineering, Tarbiat Modares University, Tehran, Iran.
Shahla NahidinezhadDepartment of Physics, Faculty of Sciences, Arak University, Arak, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe article explores the potential risk of secondary cancer (SC) due to radiation therapy (RT) and highlights the necessity for new modeling techniques to mitigate this risk.

methodsBy employing machine learning (ML) models, specifically decision trees, in the research process, a practical framework is established for forecasting the occurrence of SC using patient data. RESULTS & DISCUSSION: This framework aids in categorizing patients into high-risk or low-risk groups, thereby enabling personalized treatment plans and interventions. The paper also underscores the many factors that contribute to the likelihood of SC, such as radiation dosage, patient age, and genetic predisposition, while emphasizing the limitations of current models in encompassing all relevant parameters. These limitations arise from the non-linear dependencies between variables and the failure to consider factors such as genetics, hormones, lifestyle, radiation from secondary particles, and imaging dosage. To instruct and assess ML models for predicting the occurrence of SC based on patient data, the paper utilizes a dataset consisting of instances and attributes.

conclusionThe practical implications of this research lie in enhancing our understanding and prediction of SC following RT, facilitating personalized treatment approaches, and establishing a framework for leveraging patient data within the realm of ML models.

Indexed as

Machine LearningNeoplasms, Second PrimaryDecision TreesHumansNeoplasms, Radiation-InducedPrecision MedicineRisk AssessmentRisk Factorsdecision treesmachine learningprecision medicineradiation dosage

Identifiers

PMID39300964
PMCPMC11413496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.